Real-world evidence (RWE) has become increasingly important in healthcare decision-making as it is used ever more frequently in published research, regulatory approvals, clinical guidelines, health technology assessments, and market access decisions. RWE complements clinical trial data to provide a 360-degree view of product performance, both pre- and post-launch. This validates the product value proposition and positively informs decision-making around its use.

To fulfil the potential of RWE, relevant, clear, and actionable insights must reach healthcare stakeholders and enable evidence-based decisions. Communications strategies must therefore be employed to ensure that data dissemination is both well planned and executed effectively for optimal impact. In this white paper, we discuss best practice for integrating RWE generation with effective communications strategies to maximize the impact of RWE investment on everyday clinical practice and patient care.